• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丛状神经纤维瘤病 1 型(NF1)失活是 NF1 相关毛细胞星形细胞瘤的特征。

Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma.

机构信息

Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.

出版信息

Genome Res. 2013 Mar;23(3):431-9. doi: 10.1101/gr.142604.112. Epub 2012 Dec 5.

DOI:10.1101/gr.142604.112
PMID:23222849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3589532/
Abstract

Low-grade brain tumors (pilocytic astrocytomas) arising in the neurofibromatosis type 1 (NF1) inherited cancer predisposition syndrome are hypothesized to result from a combination of germline and acquired somatic NF1 tumor suppressor gene mutations. However, genetically engineered mice (GEM) in which mono-allelic germline Nf1 gene loss is coupled with bi-allelic somatic (glial progenitor cell) Nf1 gene inactivation develop brain tumors that do not fully recapitulate the neuropathological features of the human condition. These observations raise the intriguing possibility that, while loss of neurofibromin function is necessary for NF1-associated low-grade astrocytoma development, additional genetic changes may be required for full penetrance of the human brain tumor phenotype. To identify these potential cooperating genetic mutations, we performed whole-genome sequencing (WGS) analysis of three NF1-associated pilocytic astrocytoma (PA) tumors. We found that the mechanism of somatic NF1 loss was different in each tumor (frameshift mutation, loss of heterozygosity, and methylation). In addition, tumor purity analysis revealed that these tumors had a high proportion of stromal cells, such that only 50%-60% of cells in the tumor mass exhibited somatic NF1 loss. Importantly, we identified no additional recurrent pathogenic somatic mutations, supporting a model in which neuroglial progenitor cell NF1 loss is likely sufficient for PA formation in cooperation with a proper stromal environment.

摘要

在神经纤维瘤病 1 型(NF1)遗传癌症易感性综合征中发生的低级别的脑肿瘤(毛细胞星形细胞瘤)被假设是由于种系和获得性体细胞 NF1 肿瘤抑制基因突变为组合的结果。然而,在单等位基因种系 Nf1 基因缺失与双等位基因体细胞(神经胶质祖细胞)Nf1 基因失活相结合的基因工程小鼠(GEM)中,发展出的脑肿瘤并未完全再现人类疾病的神经病理学特征。这些观察结果提出了一个有趣的可能性,即虽然神经纤维瘤蛋白功能的丧失对于 NF1 相关的低级星形细胞瘤的发展是必要的,但是对于人类脑瘤表型的完全表现,可能还需要其他遗传变化。为了鉴定这些潜在的协同遗传突变,我们对三个 NF1 相关的毛细胞星形细胞瘤(PA)肿瘤进行了全基因组测序(WGS)分析。我们发现,每个肿瘤中体细胞 NF1 缺失的机制都不同(移码突变、杂合性缺失和甲基化)。此外,肿瘤纯度分析表明,这些肿瘤具有高比例的基质细胞,以至于肿瘤块中只有 50%-60%的细胞表现出体细胞 NF1 缺失。重要的是,我们没有发现其他复发的致病性体细胞突变,支持这样一种模型,即神经胶质祖细胞 NF1 缺失与适当的基质环境协同作用,很可能足以形成 PA。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/3589532/1dda831a943a/431fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/3589532/37253621add8/431fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/3589532/c4913d335184/431fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/3589532/1dda831a943a/431fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/3589532/37253621add8/431fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/3589532/c4913d335184/431fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/3589532/1dda831a943a/431fig3.jpg

相似文献

1
Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma.丛状神经纤维瘤病 1 型(NF1)失活是 NF1 相关毛细胞星形细胞瘤的特征。
Genome Res. 2013 Mar;23(3):431-9. doi: 10.1101/gr.142604.112. Epub 2012 Dec 5.
2
Mutational and expression analysis of the NF1 gene argues against a role as tumor suppressor in sporadic pilocytic astrocytomas.对NF1基因的突变和表达分析表明,其在散发性毛细胞型星形细胞瘤中并非肿瘤抑制基因。
J Neuropathol Exp Neurol. 2002 Oct;61(10):896-902. doi: 10.1093/jnen/61.10.896.
3
Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors.1型神经纤维瘤病(NF1)基因在患有良性和恶性肿瘤的神经纤维瘤病患者中的体细胞突变谱特征分析。
Hum Mutat. 2004 Feb;23(2):134-146. doi: 10.1002/humu.10305.
4
Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas.NF1等位基因的缺失可区分散发性与NF1相关的毛细胞型星形细胞瘤。
J Neuropathol Exp Neurol. 2001 Sep;60(9):917-20. doi: 10.1093/jnen/60.9.917.
5
Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1.对10岁后出现星形细胞瘤的1型神经纤维瘤病患者进行分子分析。
Neurology. 2003 Nov 25;61(10):1397-400. doi: 10.1212/wnl.61.10.1397.
6
Up-regulation of specific NF 1 gene transcripts in sporadic pilocytic astrocytomas.散发性毛细胞型星形细胞瘤中特定NF 1基因转录本的上调。
Am J Pathol. 1996 Aug;149(2):621-7.
7
No aberrant methylation of neurofibromatosis 1 gene (NF1) promoter in pilocytic astrocytoma in childhood.儿童毛细胞型星形细胞瘤中神经纤维瘤病1基因(NF1)启动子无异常甲基化。
Pediatr Hematol Oncol. 2005 Jan-Feb;22(1):83-7. doi: 10.1080/08880010590896440.
8
Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas.神经纤维瘤病1型(NF1)相关的毛细胞型星形细胞瘤中神经纤维瘤病1型(NF1)基因表达缺失。
Neuropathol Appl Neurobiol. 2000 Aug;26(4):361-7. doi: 10.1046/j.1365-2990.2000.00258.x.
9
The molecular and cell biology of pediatric low-grade gliomas.小儿低级别胶质瘤的分子与细胞生物学
Oncogene. 2014 Apr 17;33(16):2019-26. doi: 10.1038/onc.2013.148. Epub 2013 Apr 29.
10
Deletions on the long arm of chromosome 17 in pilocytic astrocytoma.毛细胞型星形细胞瘤中17号染色体长臂的缺失
Acta Neuropathol. 1993;86(1):81-5. doi: 10.1007/BF00454903.

引用本文的文献

1
The Molecular Basis of Pediatric Brain Tumors: A Review with Clinical Implications.小儿脑肿瘤的分子基础:一项具有临床意义的综述
Cancers (Basel). 2025 May 4;17(9):1566. doi: 10.3390/cancers17091566.
2
Targeting stromal cells in tumor microenvironment as a novel treatment strategy for glioma.将肿瘤微环境中的基质细胞作为胶质瘤的一种新型治疗策略
Cancer Cell Int. 2025 Feb 21;25(1):58. doi: 10.1186/s12935-025-03692-3.
3
Microglial Depletion, a New Tool in Neuroinflammatory Disorders: Comparison of Pharmacological Inhibitors of the CSF-1R.

本文引用的文献

1
The origin and evolution of mutations in acute myeloid leukemia.急性髓细胞白血病突变的起源和演变。
Cell. 2012 Jul 20;150(2):264-78. doi: 10.1016/j.cell.2012.06.023.
2
Innate neural stem cell heterogeneity determines the patterning of glioma formation in children.先天神经干细胞异质性决定了儿童脑胶质瘤形成的模式。
Cancer Cell. 2012 Jul 10;22(1):131-8. doi: 10.1016/j.ccr.2012.05.036.
3
Whole-genome analysis informs breast cancer response to aromatase inhibition.全基因组分析揭示了乳腺癌对芳香酶抑制的反应。
小胶质细胞清除:神经炎症性疾病的新工具——CSF-1R 药理抑制剂的比较
Glia. 2025 Apr;73(4):686-700. doi: 10.1002/glia.24664. Epub 2024 Dec 24.
4
Single-cell transcriptomics reveals IRF7 regulation of the tumor microenvironment in isocitrate dehydrogenase wild-type glioma.单细胞转录组学揭示了异柠檬酸脱氢酶野生型胶质瘤中IRF7对肿瘤微环境的调控作用。
MedComm (2020). 2024 Nov 3;5(11):e754. doi: 10.1002/mco2.754. eCollection 2024 Nov.
5
Managing neurofibromatosis type I and vision impairment in a resource-limited setting: a case study and multidisciplinary approach.在资源有限的环境中管理1型神经纤维瘤病和视力损害:一个案例研究及多学科方法
Ann Med Surg (Lond). 2024 Aug 26;86(10):6203-6207. doi: 10.1097/MS9.0000000000002482. eCollection 2024 Oct.
6
Microglia in Glioma.胶质瘤中的小胶质细胞。
Adv Neurobiol. 2024;37:513-527. doi: 10.1007/978-3-031-55529-9_28.
7
Single cell spatial biology over developmental time can decipher pediatric brain pathologies.单细胞空间生物学可解析儿童脑病理学的发育时间过程。
Neurobiol Dis. 2024 Sep;199:106597. doi: 10.1016/j.nbd.2024.106597. Epub 2024 Jul 9.
8
An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies.神经纤维瘤病 1 型伴视神经通路胶质瘤概述:发病机制、危险因素和治疗策略。
Invest Ophthalmol Vis Sci. 2024 Jun 3;65(6):8. doi: 10.1167/iovs.65.6.8.
9
Nf1 mutation disrupts activity-dependent oligodendroglial plasticity and motor learning in mice.NF1 突变破坏了小鼠活性依赖的少突胶质细胞可塑性和运动学习。
Nat Neurosci. 2024 Aug;27(8):1555-1564. doi: 10.1038/s41593-024-01654-y. Epub 2024 May 30.
10
Glioblastoma microenvironment-from biology to therapy.胶质母细胞瘤微环境——从生物学到治疗。
Genes Dev. 2024 Jun 25;38(9-10):360-379. doi: 10.1101/gad.351427.123.
Nature. 2012 Jun 10;486(7403):353-60. doi: 10.1038/nature11143.
4
BreakFusion: targeted assembly-based identification of gene fusions in whole transcriptome paired-end sequencing data.BreakFusion:基于靶向组装的全转录组配对末端测序数据中基因融合的鉴定。
Bioinformatics. 2012 Jul 15;28(14):1923-4. doi: 10.1093/bioinformatics/bts272. Epub 2012 May 4.
5
VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.VarScan 2:通过外显子组测序发现癌症中的体细胞突变和拷贝数改变。
Genome Res. 2012 Mar;22(3):568-76. doi: 10.1101/gr.129684.111. Epub 2012 Feb 2.
6
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.早期 T 细胞前体急性淋巴细胞白血病的遗传基础。
Nature. 2012 Jan 11;481(7380):157-63. doi: 10.1038/nature10725.
7
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.全基因组测序揭示复发急性髓系白血病的克隆进化。
Nature. 2012 Jan 11;481(7382):506-10. doi: 10.1038/nature10738.
8
A novel retinoblastoma therapy from genomic and epigenetic analyses.基于基因组和表观遗传学分析的新型视网膜母细胞瘤治疗方法。
Nature. 2012 Jan 11;481(7381):329-34. doi: 10.1038/nature10733.
9
High density DNA methylation array with single CpG site resolution.高分辨率单 CpG 位点的 DNA 甲基化芯片。
Genomics. 2011 Oct;98(4):288-95. doi: 10.1016/j.ygeno.2011.07.007. Epub 2011 Aug 2.
10
CREST maps somatic structural variation in cancer genomes with base-pair resolution.CREST 以碱基对分辨率绘制癌症基因组中的体细胞结构变异图谱。
Nat Methods. 2011 Jun 12;8(8):652-4. doi: 10.1038/nmeth.1628.